Article 1
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) 2024/2848 of 11 November 2024 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances fenpyrazamine and flumetralin
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in Part B, in row 25, fenpyrazamine, in the sixth column, ‘Expiration of approval’, the date is replaced by ‘15 January 2025’; (2) in Part E, in row 1, flumetralin, in the sixth column, ‘Expiration of approval’, the date is replaced by ‘15 January 2025’.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.